pubs.acs.org/joc
extended these studies to highly complex molecules contain-
Semisynthetic Derivatives of Sesquiterpene Lactones
by Palladium-Catalyzed Arylation of the
r-Methylene-γ-lactone Substructure
ing the R-methylene-γ-lactone substructure.5 Such work
would provide valuable details about the scope of these
synthetic methods.
Changho Han,† Francis J. Barrios,‡ Mark V. Riofski,† and
David A. Colby*,†,‡
†Department of Medicinal Chemistry and Molecular
Pharmacology, Purdue University, West Lafayette, Indiana
47907, and ‡Department of Chemistry, Purdue University,
West Lafayette, Indiana 47907
FIGURE 1. Products reported from Heck1 and cross-metathesis
reactions2,3 on R-methylene-γ-butyrolactone.
Received July 16, 2009
The sesquiterpene lactone class of natural products has a
diverse range of biological activities, including anticancer,
anti-inflammatory, and antiviral properties, and many con-
tain the R-methylene-γ-lactone motif.6 Recently, interest in
these natural products has dramatically increased due to
reports of anticancer stem cell activity.7 Although some
structural modifications to these natural products have been
made,6c,8-10 the direct homologation of the R-methylene-γ-
lactone substructure has not been explored. Such derivatives
would provideadditionalstructure-activitydata for this class
of natural products, because the electrophilic R-methylene-γ-
lactone is known to react with nucleophilic intracellular
thiols.6 Herein, we report our studies on the palladium-
catalyzed arylation of sesquiterpene lactones to provide
coupled products with exclusively the E-olefin geometry.
Although this stereochemical result conflicted with prior
work of Arcadi and co-workers,1 our data supports that the
The palladium-catalyzed arylation of different R-methy-
lene-γ-lactone-containing sesquiterpene lactones was
shown to produce E-olefin coupling products selectively
in moderate to excellent yields. Biological evaluation of
these semisynthetic sesquiterpene lactone derivatives in
HeLa cells showed interesting antiproliferative profiles
and provided initial structure-activity data.
(6) (a) Recent reports of anti-cancer activity: Liu, Z.; Liu, S.; Xie, Z.;
Pavlovicz, R. E.; Wu, J.; Chen, P.; Aimiuwu, J.; Pang, J.; Bhasin, D.; Neviani,
P.; Fuchs, J. R.; Plass, C.; Li, P.-K.; Li, C.; Huang, T. H. M.; Wu, L.-C.;
Rush, L.; Wang, H.; Perrotti, D.; Marcucci, G.; Chan, K. K. J. Pharmacol.
Exp. Ther. 2009, 329, 505–514. Gopal, Y. N. V.; Arora, T. S.; Van Dyke, M.
W. Chem. Biol. 2007, 14, 813–823. Steele, A. J.; Jones, D. T.; Ganeshaguru,
K.; Duke, V. M.; Yogashangary, B. C.; North, J. M.; Lowdell, M. W.;
Kottaridis, P. D.; Mehta, A. B.; Prentice, A. G.; Hoffbrand, A. V.;
Wickremasinghe, R. G. Leukemia 2006, 20, 1073–1079. Lindenmeyer,
M. T.; Hrenn, A.; Kern, C.; Castro, V.; Murillo, R.; Muller, S.; Laufer, S.;
Schulte-Monting, J.; Siedle, B.; Merfort, I. Bioorg. Med. Chem. 2006, 14,
2487–2497. (b) Anti-inflammatory activity: Wagner, S.; Hofmann, A.;
Siedle, B.; Terfloth, L.; Merfort, I.; Gasteiger, J. J. Med. Chem. 2006, 49,
2241–2252. Siedle, B.; Garcia-Pineres, A. J.; Murillo, R.; Schulte-Monting,
J.; Castro, V.; Rungeler, P.; Klaas, C. A.; Da Costa, F. B.; Kisiel, W.;
Merfort, I. J. Med. Chem. 2004, 47, 6042–6054. (c) Anti-viral activity:
Hwang, D.-R.; Wu, Y.-S.; Chang, C.-W.; Lien, T.-W.; Chen, W.-C.; Tan,
U.-K.; Hsu, J. T. A.; Hsieh, H.-P. Bioorg. Med. Chem. 2006, 14, 83–91.
(7) Guzman, M. L.; Rossi, R. M.; Karnischky, L.; Li, X.; Peterson, D. R.;
Howard, D. S.; Jordan, C. T. Blood 2005, 105, 4163–4169.
The conversion of R-methylene-γ-butyrolactone into
R-alkylidene-γ-butyrolactones via metal-catalyzed processes
has recently attracted attention to develop efficient routes to
biologically active natural products containing these func-
tional groups.1-5 Specifically, the palladium-catalyzed ary-
lation of R-methylene-γ-butyrolactone was reported to
provide a mixture of 3-benzylfuran-2(5H)-ones and R-ben-
zylidene-γ-butyrolactones with the Z-olefin geometry
(Figure 1).1 In contrast, ruthenium-catalyzed cross-metath-
esis protocols from Cossy2 and Howell3 provided the
R-alkylidene-γ-butyrolactones with excellent selectivity for
the E-olefin geometry. Thus far, no investigations have
(8) Recent examples: Nasim, S.; Crooks, P. A. Bioorg. Med. Chem. Lett.
2008, 18, 3870–3873. Srivastava, S. K.; Abraham, A.; Bhat, B.; Jaggi, M.;
Singh, A. T.; Sanna, V. K.; Singh, G.; Agarwal, S. K.; Mukherjee, R.;
Burman, A. C. Bioorg. Med. Chem. Lett. 2006, 16, 4195–4199. Macias, F. A.;
Velasco, R. F.; Alvarez, J. A.; Castellano, D.; Galindo, J. C. G. Tetrahedron
2004, 60, 8477–8488. Barrero, A. F.; Rosales, A.; Cuerva, J. M.; Oltra, J. E.
Org. Lett. 2003, 5, 1935–1938. (e) Kwok, B. H. B.; Koh, B.; Ndubuisi, M. I.;
Elofsson, M.; Crews, C. M. Chem. Biol. 2001, 8, 759–766.
(9) Structural rearrangements: Dell’Agli, M.; Galli, G. V.; Bosisio, E.;
D’Ambrosio, M. Bioorg. Med. Chem. Lett. 2009, 19, 1858–1860. Neukirch,
H.; Kaneider, N. C.; Wiedermann, C. J.; Guerriero, A.; D’Ambrosio, M.
Bioorg. Med. Chem. 2003, 11, 1503–1510. Castaneda-Acosta, J.; Fischer, N.
H.; Vargas, D. J. Nat. Prod. 1993, 56, 90–98.
(1) Arcadi, A.; Chiarini, M.; Marinelli, F.; Berente, Z.; Kollar, L. Org.
Lett. 2000, 2, 69–72. Arcadi, A.; Chiarini, M.; Marinelli, F.; Berente, Z.;
ꢀ
Kollar, L. Eur. J. Org. Chem. 2001, 16, 3165–3173.
(2) Moise, J.; Arseniyadis, S.; Cossy, J. Org. Lett. 2007, 9, 1695–1698.
(3) Raju, R.; Allen, L. J.; Le, T.; Taylor, C. D.; Howell, A. R. Org. Lett.
2007, 9, 1699–1701.
(4) Brunner, H.; Cousturier de Courcy, N. L.; Genet, J. P. Tetrahedron
Lett. 1999, 40, 4815–4818.
(5) (a) One example of an intramolecular Heck reaction has been
reported. Ishibashi, H.; Ito, K.; Hirano, T.; Tabuchi, M.; Ikdea, M.
Tetrahedron 1993, 49, 4173–4182. (b) Combinatorial libraries have recently
beenassembled from somesubstitutedR-methylene-γ-butyrolactones. Elford,
T. G.; Ulaczyk-Lesanko, A.; De Pascale, G.; Wright, G. D.; Hall, D. G.
J. Comb. Chem. 2009, 11, 155–168.
(10) Review: Minnaard, A. J.; Wijnberg, J. B. P. A.; Groot, A. D.
Tetrahedron 1999, 55, 2115–2146.
7176 J. Org. Chem. 2009, 74, 7176–7179
Published on Web 08/21/2009
DOI: 10.1021/jo901533e
r
2009 American Chemical Society